Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute urinary retention: risks and management.

Claus G Roehrborn

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Benign prostatic hyperplasia (BPH) can cause acute urinary retention (AUR). Identifying high-risk patients with factors like age, PSA, and symptom severity is key for prevention and managing AUR progression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tranexamic acid and hematuria outcomes following aquablation for benign prostatic hyperplasia.

    The Canadian journal of urology·2025
    Same author

    Direct MRI-guided In-Bore Targeted Biopsy of the Prostate: A Step-by-Step How To and Lessons Learned.

    Radiographics : a review publication of the Radiological Society of North America, Inc·2024
    Same author

    Aquablation versus TURP: 5-year outcomes of the WATER randomized clinical trial for prostate volumes 50-80 mL.

    The Canadian journal of urology·2023
    Same author

    Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression.

    Prostate cancer and prostatic diseases·2023
    Same author

    Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study.

    Urology practice·2023
    Same author

    An Actual Use Study of Tamsulosin in Men with Bothersome Urinary Symptoms in a Simulated Over-the-Counter Setting.

    Urology practice·2023
    Same journal

    Erratum: Author's Name Correction for "From Radical to Partial Nephrectomy in the Setting of Solitary Functioning Kidney: Neoadjuvant Treatment of Renal Cell Carcinoma".

    Reviews in urology·2021
    Same journal

    Update in Female Hormonal Therapy: What the Urologist Should Know: NYU Case of the Month, December 2020.

    Reviews in urology·2021
    Same journal

    Genetic Mutations Associated With Prostate Cancer and Normal Serum PSA and DRE-Implications for Prostate Cancer Screening and Management: NYU Case of the Month, November 2020.

    Reviews in urology·2021
    Same journal

    Surgical Management of the "Large" Prostate: The Robotic Simple Prostatectomy: NYU Case of the Month, October 2020.

    Reviews in urology·2021
    Same journal

    Cryptozoospermia Associated With Genital Tucking Behavior in a Transwoman.

    Reviews in urology·2021
    Same journal

    Washington Roundup.

    Reviews in urology·2021
    See all related articles

    Area of Science:

    • Urology
    • Epidemiology

    Background:

    • Acute urinary retention (AUR) from benign prostatic hyperplasia (BPH) often leads to surgery.
    • The progressive nature of BPH is increasingly recognized.
    • Epidemiological data indicate cumulative risk for AUR increases with age.

    Purpose of the Study:

    • To review risk factors and prevention strategies for AUR in BPH.
    • To inform patient counseling regarding watchful waiting for BPH.

    Main Methods:

    • Descriptive and analytical epidemiological data analysis.
    • Identification of key risk factors for AUR in BPH patients.

    Main Results:

    • Serum prostate-specific antigen (PSA), prostate volume, maximum flow rate, and symptom severity are significant risk factors.

    Related Experiment Videos

  • Older age, severe symptoms, larger prostate, and higher PSA identify high-risk individuals.
  • Finasteride shows risk reduction, and alpha-blockers assist spontaneous voiding post-AUR.

    • Conclusions:

    • Primary prevention of AUR should target high-risk BPH patients.
    • Risk stratification aids in managing BPH and preventing AUR.
    • Pharmacological interventions can reduce AUR risk and aid recovery.